Biotech Growth Trust (The) (LSE:BIOG) ROC %: % (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:BIOG Biotech Growth Trust (The) PLC LSE:BIOG
30 GF Score
Price £17.38
! 4 Warning Signs
View Full Analysis

What is Biotech Growth Trust (The) ROC %?

Biotech Growth Trust (The) LSE:BIOG +1.26% 30 ROC % is % as of Mar. 2026. GuruFocus rates LSE:BIOG with a GF Score™ of 30/100. The stock has 4 warning signs investors should review.

ROC %does not apply to banks.

LSE:BIOG
30GF Score
Biotech Growth Trust (The) PLC LSE:BIOG
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROC % →
What does a ROC % of % mean?
Biotech Growth Trust (The) (LSE:BIOG) has a ROC % of % as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Biotech Growth Trust (The) and its competitors.
Is Biotech Growth Trust (The)'s ROC % too high?
Biotech Growth Trust (The)'s current ROC % is %. Overall, Biotech Growth Trust (The) has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Biotech Growth Trust (The)'s ROC % compare to BLK and BX?
Biotech Growth Trust (The)'s ROC % of % can be compared against companies in the Asset Management industry. The industry median ROC % is 1.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for an Asset Management company?
The median ROC % among Asset Management companies is 1.64, based on 714 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Biotech Growth Trust (The) and its competitors. For the Asset Management industry, the median ROC % is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotech Growth Trust (The)'s current ROC % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotech Growth Trust (The) stock overvalued right now?
Biotech Growth Trust (The) (LSE:BIOG) has a current ROC % of %. The current ROC % is %. Biotech Growth Trust (The)'s overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Biotech Growth Trust (The) (LSE:BIOG), the current ROC % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotech Growth Trust (The) Business Description

Address 25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is an externally managed investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world.
30GF Score

Get the complete analysis for LSE:BIOG

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£17.38
Price